Login to Your Account



FDA Advisers to Examine KRAS Studies for Erbitux, Vectibix Labels

By Donna Young


Tuesday, December 16, 2008
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription